KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Return on Sales (2016 - 2025)

Historic Return on Sales for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to 0.14%.

  • Neogenomics' Return on Sales fell 400.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.12% for FY2024, which is 300.0% up from last year.
  • Per Neogenomics' latest filing, its Return on Sales stood at 0.14% for Q3 2025, which was down 400.0% from 0.25% recorded in Q2 2025.
  • Over the past 5 years, Neogenomics' Return on Sales peaked at 0.62% during Q2 2021, and registered a low of 0.42% during Q1 2022.
  • Over the past 5 years, Neogenomics' median Return on Sales value was 0.17% (recorded in 2023), while the average stood at 0.15%.
  • Per our database at Business Quant, Neogenomics' Return on Sales surged by 7000bps in 2021 and then tumbled by -9100bps in 2022.
  • Over the past 5 years, Neogenomics' Return on Sales (Quarter) stood at 0.33% in 2021, then soared by 51bps to 0.16% in 2022, then soared by 44bps to 0.09% in 2023, then increased by 3bps to 0.09% in 2024, then plummeted by -62bps to 0.14% in 2025.
  • Its Return on Sales was 0.14% in Q3 2025, compared to 0.25% in Q2 2025 and 0.15% in Q1 2025.